Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1992 Nov;107(3):705–709. doi: 10.1111/j.1476-5381.1992.tb14510.x

Effects of the PAF antagonists BN50726 and BN50739 on arrhythmogenesis and extent of necrosis during myocardial ischaemia/reperfusion in rabbits.

S Chakrabarty 1, D S Fluck 1, N A Flores 1, D J Sheridan 1
PMCID: PMC1907739  PMID: 1472967

Abstract

1. The effects of two novel platelet activating factor (PAF) antagonists BN50726 and BN50739 on arrhythmias, haemodynamics and extent of necrosis during myocardial ischaemia and reperfusion were investigated in anaesthetized rabbits subjected to coronary artery ligation. 2. BN50739 reduced heart rate prior to coronary artery occlusion (P < 0.005) but had no other significant haemodynamic effects at this time. BN50739 and BN50726 did not significantly alter heart rate or blood pressure during 30 min of ischaemia or 30 min of reperfusion, compared to control hearts. 3. BN50739 and BN50726 had no effect on the incidence of arrhythmias during ischaemia. BN50726 significantly reduced the incidence of reperfusion ventricular fibrillation compared to controls (0% v 40%, P < 0.05), and improved survival (80% v 39%, P < 0.05). Similar trends were observed with BN50739. 4. BN50726 reduced the extent of necrosis compared to control hearts (18 +/- 2% v 30 +/- 3%, P < 0.01). A similar trend was observed with BN50739. 5. These results demonstrate that PAF antagonism with BN50726 attenuates reperfusion-induced arrhythmias and preserves myocardium in the early phase of ischaemia, independently of haemodynamic effects.

Full text

PDF
705

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cargill D. I., Cohen D. S., Van Valen R. G., Klimek J. J., Levin R. P. Aggregation, release and desensitization induced in platelets from five species by platelet activating factor (PAF). Thromb Haemost. 1983 Jun 28;49(3):204–207. [PubMed] [Google Scholar]
  2. Chakrabarty S., Thomas P., Sheridan D. J. Arrhythmias, haemodynamic changes and extent of myocardial damage during coronary ligation in rabbits anaesthetized with halothane, alpha chloralose or pentobarbitone. Int J Cardiol. 1991 Apr;31(1):9–14. doi: 10.1016/0167-5273(91)90261-m. [DOI] [PubMed] [Google Scholar]
  3. Chakrabarty S., Thomas P., Sheridan D. J. Contribution of platelets and platelet-activating factor (PAF) to the arrhythmogenic, haemodynamic and necrotic effects of acute myocardial ischaemia. Eur Heart J. 1991 May;12(5):583–589. doi: 10.1093/oxfordjournals.eurheartj.a059944. [DOI] [PubMed] [Google Scholar]
  4. Flores N. A., Davies R. L., Penny W. J., Sheridan D. J. Coronary microangiography in the guinea pig, rabbit and ferret. Int J Cardiol. 1984 Oct;6(4):459–471. doi: 10.1016/0167-5273(84)90326-7. [DOI] [PubMed] [Google Scholar]
  5. Flores N. A., Sheridan D. J. Electrophysiological and arrhythmogenic effects of platelet activating factor during normal perfusion, myocardial ischaemia and reperfusion in the guinea-pig. Br J Pharmacol. 1990 Nov;101(3):734–738. doi: 10.1111/j.1476-5381.1990.tb14149.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Koltai M., Tosaki A., Hosford D., Esanu A., Braquet P. Effect of BN 50739, a new platelet activating factor antagonist, on ischaemia induced ventricular arrhythmias in isolated working rat hearts. Cardiovasc Res. 1991 May;25(5):391–397. doi: 10.1093/cvr/25.5.391. [DOI] [PubMed] [Google Scholar]
  7. Lotner G. Z., Lynch J. M., Betz S. J., Henson P. M. Human neutrophil-derived platelet activating factor. J Immunol. 1980 Feb;124(2):676–684. [PubMed] [Google Scholar]
  8. Maruyama M., Farber N. E., Vercellotti G. M., Jacob H. S., Gross G. J. Evidence for a role of platelet activating factor in the pathogenesis of irreversible but not reversible myocardial injury after reperfusion in dogs. Am Heart J. 1990 Sep;120(3):510–520. doi: 10.1016/0002-8703(90)90003-g. [DOI] [PubMed] [Google Scholar]
  9. McManus L. M., Hanahan D. J., Pinckard R. N. Human platelet stimulation by acetyl glyceryl ether phosphorylcholine. J Clin Invest. 1981 Mar;67(3):903–906. doi: 10.1172/JCI110108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Mehta P., Mehta J. Platelet function studies in coronary artery disease. V. Evidence for enhanced platelet microthrombus formation activity in acute myocardial infarction. Am J Cardiol. 1979 Apr;43(4):757–760. doi: 10.1016/0002-9149(79)90075-4. [DOI] [PubMed] [Google Scholar]
  11. Mickelson J. K., Simpson P. J., Lucchesi B. R. Myocardial dysfunction and coronary vasoconstriction induced by platelet-activating factor in the post-infarcted rabbit isolated heart. J Mol Cell Cardiol. 1988 Jun;20(6):547–561. doi: 10.1016/s0022-2828(88)80081-6. [DOI] [PubMed] [Google Scholar]
  12. Mikhailidis D. P., Barradas M. A., Mier A., Boag F., Jeremy J. Y., Havard C. W., Dandona P. Platelet function in patients admitted with a diagnosis of myocardial infarction. Angiology. 1987 Jan;38(1 Pt 1):36–45. doi: 10.1177/000331978703800105. [DOI] [PubMed] [Google Scholar]
  13. Montrucchio G., Alloatti G., Mariano F., de Paulis R., Comino A., Emanuelli G., Camussi G. Role of platelet-activating factor in the reperfusion injury of rabbit ischemic heart. Am J Pathol. 1990 Jul;137(1):71–83. [PMC free article] [PubMed] [Google Scholar]
  14. Montrucchio G., Alloatti G., Tetta C., De Luca R., Saunders R. N., Emanuelli G., Camussi G. Release of platelet-activating factor from ischemic-reperfused rabbit heart. Am J Physiol. 1989 Apr;256(4 Pt 2):H1236–H1246. doi: 10.1152/ajpheart.1989.256.4.H1236. [DOI] [PubMed] [Google Scholar]
  15. Montrucchio G., Camussi G., Tetta C., Emanuelli G., Orzan F., Libero L., Brusca A. Intravascular release of platelet-activating factor during atrial pacing. Lancet. 1986 Aug 2;2(8501):293–293. doi: 10.1016/s0140-6736(86)92118-5. [DOI] [PubMed] [Google Scholar]
  16. Rösen R., Dausch W., Beck E., Klaus W. Platelet induced aggravation of acute ischaemia in an isolated rabbit heart model. Cardiovasc Res. 1987 Apr;21(4):293–298. doi: 10.1093/cvr/21.4.293. [DOI] [PubMed] [Google Scholar]
  17. Sisson J. H., Prescott S. M., McIntyre T. M., Zimmerman G. A. Production of platelet-activating factor by stimulated human polymorphonuclear leukocytes. Correlation of synthesis with release, functional events, and leukotriene B4 metabolism. J Immunol. 1987 Jun 1;138(11):3918–3926. [PubMed] [Google Scholar]
  18. Stahl G. L., Terashita Z., Lefer A. M. Role of platelet activating factor in propagation of cardiac damage during myocardial ischemia. J Pharmacol Exp Ther. 1988 Mar;244(3):898–904. [PubMed] [Google Scholar]
  19. Stewart A. G., Dusting G. J. Characterization of receptors for platelet-activating factor on platelets, polymorphonuclear leukocytes and macrophages. Br J Pharmacol. 1988 Aug;94(4):1225–1233. doi: 10.1111/j.1476-5381.1988.tb11642.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Tamargo J., Tejerina T., Delgado C., Barrigon S. Electrophysiological effects of platelet-activating factor (PAF-acether) in guinea-pig papillary muscles. Eur J Pharmacol. 1985 Feb 26;109(2):219–227. doi: 10.1016/0014-2999(85)90423-6. [DOI] [PubMed] [Google Scholar]
  21. Wainwright C. L., Parratt J. R., Bigaud M. The effects of PAF antagonists on arrhythmias and platelets during acute myocardial ischaemia and reperfusion. Eur Heart J. 1989 Mar;10(3):235–243. doi: 10.1093/oxfordjournals.eurheartj.a059471. [DOI] [PubMed] [Google Scholar]
  22. Walker M. J., Curtis M. J., Hearse D. J., Campbell R. W., Janse M. J., Yellon D. M., Cobbe S. M., Coker S. J., Harness J. B., Harron D. W. The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion. Cardiovasc Res. 1988 Jul;22(7):447–455. doi: 10.1093/cvr/22.7.447. [DOI] [PubMed] [Google Scholar]
  23. Yamanaka S., Miura K., Yukimura T., Okumura M., Yamamoto K. Putative mechanism of hypotensive action of platelet-activating factor in dogs. Circ Res. 1992 May;70(5):893–901. doi: 10.1161/01.res.70.5.893. [DOI] [PubMed] [Google Scholar]
  24. Yue T. L., Rabinovici R., Farhat M., Feuerstein G. Pharmacologic profile of BN 50739, a new PAF antagonist in vitro and in vivo. Prostaglandins. 1990 May;39(5):469–480. doi: 10.1016/0090-6980(90)90031-p. [DOI] [PubMed] [Google Scholar]
  25. Zimmerman G. A., McIntyre T. M., Prescott S. M. Production of platelet-activating factor by human vascular endothelial cells: evidence for a requirement for specific agonists and modulation by prostacyclin. Circulation. 1985 Oct;72(4):718–727. doi: 10.1161/01.cir.72.4.718. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES